Related Experiment Video
Updated: Jun 10, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Neuropsychological deficits in adolescent methamphetamine abusers
George King1, Daniel Alicata, Christine Cloak
1Department of Psychiatry, John A Burns School of Medicine, 1356 Lusitana St 4th Floor, Honolulu, HI 96813, USA. grking@hawaii.edu
Adolescent methamphetamine (METH) users show impaired executive functions and psychomotor speed compared to non-users. Abstinence duration correlates with improved cognitive performance, suggesting potential for recovery in young METH users.
Area of Science:
- Neuroscience
- Psychiatry
- Developmental Psychology
Background:
- Methamphetamine (METH) abuse is linked to neurotoxicity and cognitive deficits in adults.
- The impact of METH on adolescent neurocognition remains largely unexamined.
Purpose of the Study:
- To investigate the neurocognitive effects of METH use in adolescents.
- To assess specific cognitive domains affected by METH in this age group.
Main Methods:
- Neuropsychological testing of 54 adolescent METH users and 74 controls (ages 12-23).
- Evaluated domains included psychomotor speed, executive function, fine-motor speed, memory, attention, and working memory.
Main Results:
- METH users exhibited slower performance on the Stroop Interference task and poorer scores on the WAIS/WISC Matrices task.
- Adolescent METH users were significantly impaired on the Grooved Pegboard task for both dominant and non-dominant hands.
- Longer abstinence correlated with better performance on the Peg Board and Digit Span tasks.
Conclusions:
- Methamphetamine use is associated with significant impairments in executive functions among adolescent users.
- Findings highlight the detrimental effects of METH on adolescent brain development and cognitive abilities.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

